PCRX

Pacira BioSciences, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$36.46

Price (1 Year)

$36.46 $19.16

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %26.8 / %30
Non-compliant assets / Total market cap %4.4 / %30
Non-compliant revenue / Total income %1.2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve.

Website

Analysis (Turkish): PCRX Hissesi Caiz mi, Helal mi? Pacira BioSciences, Inc. Katılım Analizi